Abstract
Escherichia coli KA0011 had stable minimum inhibitory concentration values around the breakpoint range of meropenem and imipenem, making it suitable for use as a quality control strain for antimicrobial susceptibility testing. Here, we report the complete genomic sequence of KA0011.
Funding Information
  • Japan Agency for Medical Research and Development (JP22fk0108604)
  • Japan Agency for Medical Research and Development (JP23fk0108604)
  • Japan Agency for Medical Research and Development (JP22fk0108636)
  • Japan Agency for Medical Research and Development (JP23fk0108636)